日本不整脈心電学会

HOME > 英文誌 Journal of Arrhythmia > JoA検索サイト

JoA検索サイト

deactivation

Deactivation of implantable cardioverter defibrillator in Japanese patients with end-stage heart failure

ページの先頭へ

deep sedation

Outcomes of Deep Sedation for Catheter Ablation of Paroxysmal Supraventricular Tachycardia, with Adaptive Servo Ventilation

ページの先頭へ

defibrillation device

Reassessment of practical usage and accumulation of real-world data of wearable cardioverter defibrillator (WCD) in Japan –Design paper for J-WCDR study-

ページの先頭へ

Defibrillator

Cardiac Implantable Devices During Exercise: Normal Function and Troubleshooting

ページの先頭へ

device interrogation

First reported case of a longevity overestimation error in the new Medtronic tablet-based device programmer

ページの先頭へ

dexmedetomidine

Outcomes of Deep Sedation for Catheter Ablation of Paroxysmal Supraventricular Tachycardia, with Adaptive Servo Ventilation

ページの先頭へ

diagnoses

Creating 12-lead electrocardiogram waveforms using a three-lead bedside monitor to ensure appropriate monitoring

ページの先頭へ

Diagnosis Procedure Combination database

Patient Characteristics, Procedure Details Including Catheter Devices, and Complications of Catheter Ablation for Ventricular Tachycardia: A Nationwide Observational Study

ページの先頭へ

dialysis and transplantation

Effect of dialysis and transplantation on myocardial repolarization parameters and P-wave dispersion in chronic kidney disease

ページの先頭へ

digital medicine

2020 ISHNE/ HRS/ EHRA/ APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals

ページの先頭へ

direct oral anticoagulant

Coagulation and heparin requirements during ablation in patients under oral anticoagulant drugs

Electronic monitoring of adherence to once-daily and twice-daily direct oral anticoagulants in patients with atrial fibrillation: baseline data from the SMAAP-AF trial

ページの先頭へ

direct oral anticoagulants

Relationship Between the Degree of Renal Dysfunction and the Safety and Efficacy Outcomes in Patients with Atrial Fibrillation Receiving Direct Oral Anticoagulants

Outcomes of Uninterrupted vs Interrupted Periprocedural Direct Oral Anticoagulants in Atrial Fibrillation Ablation: A Meta-Analysis

ページの先頭へ

direct-acting oral anticoagulants

Safety and effectiveness of edoxaban in Japanese patients with nonvalvular atrial fibrillation: Final report of a two-year postmarketing surveillance study (ETNA-AF-Japan)

ページの先頭へ

directional high-density mapping catheter

High-density mapping of multiple atypical atrial flutter. First HD GRID mapping experience among The Commonwealth of Independent States.

ページの先頭へ

do not attempt resuscitation

Deactivation of implantable cardioverter defibrillator in Japanese patients with end-stage heart failure

ページの先頭へ

DOAC

Nine-year trend of oral anticoagulant use in patients with embolic stroke due to nonvalvular atrial fibrillation

Anticoagulant activity of apixaban can be estimated by multiple regression analysis

ページの先頭へ

dosing frequency

Electronic monitoring of adherence to once-daily and twice-daily direct oral anticoagulants in patients with atrial fibrillation: baseline data from the SMAAP-AF trial

ページの先頭へ

dual-chamber pacemaker

Association between routine biomarkers and atrial fibrillation in patients undergoing implantation of a dual chamber pacemaker**

ページの先頭へ

durometer measurements

Baseline Incision Characteristics and Early Scar Maturation Indices Following Cardiac Device Implantation

ページの先頭へ

duty-cycled radiofrequency

Correlation of pulmonary vein reconnection patterns after cryoballoon and duty-cycled ablation of atrial fibrillation with the time of arrhythmia recurrence

ページの先頭へ

dysrhythmia

Arrhythmia in Tumor Lysis Syndrome and Associated In-hospital Mortality: A Nationwide Inpatient Analysis

ページの先頭へ

dyssynchrony

Evaluation of ivabradine in left ventricular dyssynchrony and reverse remodeling in patients with chronic heart failure

TOP